Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
uridine triacetate
DRUG
2 trials
Sponsors
Wellstat Therapeutics
Conditions
Hereditary Orotic Aciduria
Toxicity Due to Chemotherapy
Phase 3
Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria
Completed
NCT02110147
Wellstat Therapeutics
Hereditary Orotic Aciduria
Start: 2014-04-30
End: 2016-09-08
Updated: 2017-07-31
Unknown Phase
Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination
NCT01432301
Wellstat Therapeutics
Toxicity Due to Chemotherapy
Updated: 2016-03-07
Related Papers
Clinical trial experience with uridine triacetate for 5-fluorouracil toxicity.
Journal of Clinical Oncology
2016-02-01
3 citations